Annexon (ANNX) Common Equity (2019 - 2026)
Annexon (ANNX) reported Common Equity of $186.06 million for Q2 2026, down 6.5% from $199.02 million a year earlier and down 9.0% from the prior quarter.
Annexon (ANNX) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Annexon posted Common Equity of $211.65 million, down 27.8% from FY2024.
- Common Equity has a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
- By year, Common Equity came in at $293.11 million in FY2024 (+17.0%), $250.56 million in FY2023 (+8.4%), $231.19 million in FY2022 (-0.3%) and $231.91 million in FY2021 (-32.6%).
- Five-year quarterly Common Equity spans a low of $156.84 million in Q3 2023 and a high of $361.08 million in Q2 2024.
- Year over year, Common Equity has now declined in each of the last six quarters, with an average decline of 3.2% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q3 2024 (growth of 111.4%); the low point was Q3 2025 (a decline of 51.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $204.53 million (Q1 2026), $211.65 million (Q4 2025) and $161.44 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Annexon | 700.16 Mn | 700.16 Mn | - | 186.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186.06 Mn |
| Mar 31, 2026 | 204.53 Mn |
| Dec 31, 2025 | 211.65 Mn |
| Sep 30, 2025 | 161.44 Mn |
| Jun 30, 2025 | 199.02 Mn |
| Mar 31, 2025 | 243.79 Mn |
| Dec 31, 2024 | 293.11 Mn |
| Sep 30, 2024 | 331.56 Mn |
| Jun 30, 2024 | 361.08 Mn |
| Mar 31, 2024 | 262.41 Mn |
| Dec 31, 2023 | 250.56 Mn |
| Sep 30, 2023 | 156.84 Mn |
| Jun 30, 2023 | 184.72 Mn |
| Mar 31, 2023 | 214.86 Mn |
| Dec 31, 2022 | 231.19 Mn |
| Sep 30, 2022 | 260.60 Mn |
| Jun 30, 2022 | 168.04 Mn |
| Mar 31, 2022 | 200.61 Mn |
| Dec 31, 2021 | 231.91 Mn |
| Sep 30, 2021 | 264.48 Mn |
Annexon Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ANNX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ANNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ANNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();